Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease

BACKGROUND: Several evidences suggest that failure of synaptic function occurs at preclinical stages of Alzheimer’s disease (AD) preceding neuronal loss and the classical AD pathological hallmarks. Nowadays, there is an urgent need to identify reliable biomarkers that could be obtained with non-inva...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Res Ther
Autores principales: Siedlecki-Wullich, Dolores, Català-Solsona, Judit, Fábregas, Cristina, Hernández, Isabel, Clarimon, Jordi, Lleó, Alberto, Boada, Merce, Saura, Carlos A., Rodríguez-Álvarez, José, Miñano-Molina, Alfredo J.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6521366/
https://ncbi.nlm.nih.gov/pubmed/31092279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-019-0501-4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares